These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25118673)

  • 21. Small molecules targeting sodium and calcium channels for neuropathic pain.
    Bear B; Asgian J; Termin A; Zimmermann N
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse.
    Toba Y; Pakiam JG; Wray S
    Eur J Neurosci; 2005 Jul; 22(1):79-92. PubMed ID: 16029198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulators of voltage-dependent calcium channels for the treatment of nervous system diseases.
    Takahashi E; Niimi K
    Recent Pat CNS Drug Discov; 2009 Jun; 4(2):96-111. PubMed ID: 19519559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphenol A inhibits voltage-activated Ca(2+) channels in vitro: mechanisms and structural requirements.
    Deutschmann A; Hans M; Meyer R; Häberlein H; Swandulla D
    Mol Pharmacol; 2013 Feb; 83(2):501-11. PubMed ID: 23197648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of L-type calcium channel antagonists on spermine-induced CNS excitation in vivo.
    Doyle KM; Kirby BP; Murphy D; Shaw GG
    Neurosci Lett; 2005 Jun; 380(3):247-51. PubMed ID: 15862895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High voltage-activated Ca(2+) channel currents in isolectin B(4)-positive and -negative small dorsal root ganglion neurons of rats.
    Wu ZZ; Pan HL
    Neurosci Lett; 2004 Sep; 368(1):96-101. PubMed ID: 15342142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-type calcium channels blocked by the spider toxin omega-Aga-IVA.
    Mintz IM; Venema VJ; Swiderek KM; Lee TD; Bean BP; Adams ME
    Nature; 1992 Feb; 355(6363):827-9. PubMed ID: 1311418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-threshold calcium currents in central nervous system neurons.
    Huguenard JR
    Annu Rev Physiol; 1996; 58():329-48. PubMed ID: 8815798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium channel blockers: a patent review (2010 - 2014).
    Zuliani V; Rapalli A; Patel MK; Rivara M
    Expert Opin Ther Pat; 2015 Mar; 25(3):279-90. PubMed ID: 25539043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonists of neuronal calcium channels: structure, function, and therapeutic implications.
    Miljanich GP; Ramachandran J
    Annu Rev Pharmacol Toxicol; 1995; 35():707-34. PubMed ID: 7598513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices.
    Thurgur C; Church J
    Br J Pharmacol; 1998 Jul; 124(5):917-29. PubMed ID: 9692777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel blockers and dementia.
    Nimmrich V; Eckert A
    Br J Pharmacol; 2013 Jul; 169(6):1203-10. PubMed ID: 23638877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-voltage-activated Ca2+ currents show similar patterns of expression in stellate and pyramidal cells from rat entorhinal cortex layer II.
    Castelli L; Magistretti J
    Brain Res; 2006 May; 1090(1):76-88. PubMed ID: 16674933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking of L-type calcium channels protects hippocampal and nigral neurons against iron neurotoxicity. The role of L-type calcium channels in iron-induced neurotoxicity.
    Bostanci MÖ; Bagirici F
    Int J Neurosci; 2013 Dec; 123(12):876-82. PubMed ID: 23768064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-type calcium channels as drug targets in CNS disorders.
    Ortner NJ; Striessnig J
    Channels (Austin); 2016; 10(1):7-13. PubMed ID: 26039257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ion channels as drug targets in central nervous system disorders.
    Waszkielewicz AM; Gunia A; Szkaradek N; Słoczyńska K; Krupińska S; Marona H
    Curr Med Chem; 2013; 20(10):1241-85. PubMed ID: 23409712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Voltage-Activated Calcium Channel in the Afferent Pain Pathway: An Important Target of Pain Therapies.
    Li Q; Lu J; Zhou X; Chen X; Su D; Gu X; Yu W
    Neurosci Bull; 2019 Dec; 35(6):1073-1084. PubMed ID: 31065935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
    Zamponi GW
    Nat Rev Drug Discov; 2016 Jan; 15(1):19-34. PubMed ID: 26542451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.